Therefore, identifying and functionally characterizing enhancer elements that control sox10 expression during this oncogenic transition will broaden our understanding of transcriptional and, eventually, epigenetic changes that occur to trigger melanoma initiation and activation of an NCP-like identity from within a cancerized field. The gene discussed is SOX10; the disease is melanoma.